Breast Cancer Research and Treatment

, Volume 7, Issue 1, pp 47–48 | Cite as

Complete response in metastatic breast cancer

  • Charles Vogel


Public Health Breast Cancer Metastatic Breast Cancer Metastatic Breast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Tormey DC, Kline JC, Palta M, Davis TE, Love RR, Carbone PP: Short term high density systemic therapy for metastatic breast cancer. Breast Cancer Res Treat 5: 177–188, 1985PubMedGoogle Scholar
  2. 2.
    Allegra JC, Woodcock TM, Richman SP, Kirby IB, Wittliff JL: A phase II trial of Tamoxifen, Premarin, Methotrexate and 5-Fluorouracil in metastatic breast cancer. Breast Cancer Res Treat 2: 93–100, 1982PubMedGoogle Scholar
  3. 3.
    Smalley RV, Bartolucci A, for the Southeastern Cancer Study Group: Variation in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.In: Mouridsen HT, Palshof T (eds): Breast Cancer — Experimental and Clinical Aspects. Pergamon Press, New York, 1980, pp 141–146Google Scholar
  4. 4.
    Lippman M, Sorace R, Bagley C, Lichter A, Danforth D, Wesley M, Young R: Effective systemic management of locally advanced breast cancer. Proc ASCO 1: 65, 1985Google Scholar
  5. 5.
    Burchenal JH: From wild fowl to stalking horses: alchemy in chemotherapy. Fifth Annual David A. Karnofsky Memorial Lecture. Cancer 35: 1121–1131, 1975Google Scholar

Copyright information

© Martinus Nijhoff Publishers 1986

Authors and Affiliations

  • Charles Vogel

There are no affiliations available

Personalised recommendations